Skip to main content
Log in

Percutaneous Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma After Hepatectomy: Long-term Results and Prognostic Factors

  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

We evaluated the long-term survival results and safety of percutaneous radiofrequency ablation (RFA) for recurrent hepatocellular carcinoma (HCC) after hepatectomy, and assessed the prognostic factors that can influence its long-term therapeutic results.

Methods

One hundred and two patients, who had 119 recurrent HCC in their livers, underwent ultrasound-guided percutaneous RFA. All the patients had a history of hepatic resection as a first-line treatment modality for HCC. The mean diameter of the recurrent tumors was 2.0 cm (range, 0.8–5.0 cm). We evaluated the effectiveness rates, local tumor progression rates, survival rates, and complications. We also assessed the prognostic factors of the survival rates by using Cox proportional hazard models.

Results

The primary effectiveness rate was 93.3% (111 of 119). The cumulative rates of local tumor progression at 1, 3, and 5 years were 6.0, 8.6, and 11.9%, respectively. The cumulative survival rates at 1, 2, 3, 4, and 5 years were 93.9, 83.7, 65.7, 56.6, and 51.6%, respectively. Patients with a lower serum α-fetoprotein (AFP) level (≤100 μg/L) before RFA or with small resected tumors (≤5 cm) demonstrated better survival results (P < .05). There was only one major complication (liver abscess, 1.0% per treatment) during the follow-up period. There were no procedure-related deaths.

Conclusions

Percutaneous RFA is an effective and safe treatment modality for intrahepatic recurrent HCC after hepatectomy. Serum AFP level before RFA and resected tumor size were significant prognostic predictors of long-term survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

FIG. 1.
FIG. 2.

Similar content being viewed by others

References

  1. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362:1907–1917

    Article  PubMed  Google Scholar 

  2. Balsells J, Charco R, Lazaro JL, Murio E, Vargas V, Allende E, Margarite C. Resection of hepatocellular carcinoma in patients with cirrhosis. Br J Surg 1996; 83:758–761

    Article  PubMed  CAS  Google Scholar 

  3. Shuto T, Kinoshita H, Hirohashi K, et al. Indications for, and effectiveness of, a second hepatic resection for recurrent hepatocellular carcinoma. Hepatogastroenterology 1996; 43:932–937

    PubMed  CAS  Google Scholar 

  4. Takenaka K, Kawahara N, Yamamoto K, et al. Results of 280 liver resections for hepatocellular carcinoma. Arch Surg 1996; 131:71–76

    PubMed  CAS  Google Scholar 

  5. Sugimachi K, Maehara S, Tanaka S, Shimada M, Sugimachi K. Repeat hepatectomy is the most useful treatment for recurrent hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 2001; 8:410–416

    Article  PubMed  CAS  Google Scholar 

  6. Matsuda M, Fujii H, Kono H, Matsumoto Y. Surgical treatment of recurrent hepatocellular carcinoma based on the mode of recurrence: repeat hepatic resection or ablation are good choices for patients with recurrent multicentric cancer. J Hepatobiliary Pancreat Surg 2001; 8:353–359

    Article  PubMed  CAS  Google Scholar 

  7. Suenaga M, Sugiura H, Kokuba Y, Uehara S, Kurumiya T. Repeated hepatic resection for recurrent hepatocellular carcinoma in 18 cases. Surgery 1994; 115:452–457

    PubMed  CAS  Google Scholar 

  8. Neeleman N, Andersson R. Repeat liver resection for recurrent liver cancer. Br J Surg 1996; 83:893–901

    Article  PubMed  CAS  Google Scholar 

  9. Capussotti L, Borgonovo G, Bouzari H, Smadja C, Grange D, Franco D. Results of major hepatectomy for large primary liver cancer in patients with cirrhosis. Br J Surg 1994; 81:427–431

    Article  PubMed  CAS  Google Scholar 

  10. Hu RH, Lee PH, Yu SC, et al. Surgical resection for recurrent hepatocellular carcinoma: prognosis and analysis of risk factors. Surgery 1996; 120:23–29

    Article  PubMed  CAS  Google Scholar 

  11. Shimada M, Takenaka K, Taguchi K, et al. Prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma. Ann Surg 1998; 227:80–85

    Article  PubMed  CAS  Google Scholar 

  12. Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg 1999; 229:216–222

    Article  PubMed  CAS  Google Scholar 

  13. Takayasu K, Wakao F, Moriyama N, et al. Postresection recurrence of hepatocellular carcinoma treated by arterial embolization: analysis of prognostic factors. Hepatology 1992; 16:906–911

    Article  PubMed  CAS  Google Scholar 

  14. Okazaki M, Yamasaki S, Ono H, et al. Chemoembolotherapy for recurrent hepatocellular carcinoma in the residual liver after hepatectomy. Hepatogastroenterology 1993; 40:320–323

    PubMed  CAS  Google Scholar 

  15. Shimada M, Takenaka K, Gion T, et al. Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan. Gastroenterology 1996; 111:720–726

    Article  PubMed  CAS  Google Scholar 

  16. Kainuma O, Asano T, Aoyama H, Shinohara Y. Recurrent hepatocellular carcinoma successfully treated with radiofrequency thermal ablation. J Hepatobiliary Pancreat Surg 1999; 6:190–194

    Article  PubMed  CAS  Google Scholar 

  17. Nicoli N, Casaril A, Marchiori L, Mangiante G, Hasheminia AR. Treatment of recurrent hepatocellular carcinoma by radiofrequency thermal ablation. J Hepatobiliary Pancreat Surg 2001; 8:417–421

    Article  PubMed  CAS  Google Scholar 

  18. Elias D, de Baere T, Smayra T, Ouellet JF, Roche A, Lasser P. Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy. Br J Surg 2002; 89:752–756

    Article  PubMed  CAS  Google Scholar 

  19. Choi D, Lim HK, Kim MJ, et al. Recurrent hepatocellular carcinoma: percutaneous radiofrequency ablation after hepatectomy. Radiology 2004; 230:135–141

    Article  PubMed  Google Scholar 

  20. Lu MD, Yin XY, Xie XY, et al. Percutaneous thermal ablation for recurrent hepatocellular carcinoma after hepatectomy. Br J Surg 2005; 92:1393–1398

    Article  PubMed  Google Scholar 

  21. Yang W, Chen MH, Yin SS, et al. Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy: therapeutic efficacy on early- and late-phase recurrence. AJR Am J Roentgenol 2006; 186:S275–283

    Article  PubMed  Google Scholar 

  22. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35:421–430

    Article  PubMed  CAS  Google Scholar 

  23. Goldberg SN, Grassi CJ, Cardella JF, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 2005; 235:728–739

    Article  PubMed  Google Scholar 

  24. Choi D, Lim HK, Kim SH, et al. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results. Radiology 2000; 217:558–563

    PubMed  CAS  Google Scholar 

  25. Choi D, Lim HK, Lee WJ, et al. Radiofrequency ablation of liver cancer: early evaluation of therapeutic response with contrast-enhanced ultrasonography. Korean J Radiol 2004; 5:185–198

    Article  PubMed  Google Scholar 

  26. Lim HK, Choi D, Lee WJ, et al. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: evaluation with follow-up multiphase helical CT. Radiology 2001; 221:447–454

    Article  PubMed  CAS  Google Scholar 

  27. Nagasue N, Kohno H, Hayashi T, et al. Repeat hepatectomy for recurrent hepatocellular carcinoma. Br J Surg 1996; 83:127–131

    Article  PubMed  CAS  Google Scholar 

  28. Arii S, Teramoto K, Kawamura T, et al. Characteristics of recurrent hepatocellular carcinoma in Japan and our surgical experience. J Hepatobiliary Pancreat Surg 2001; 8:397–403

    Article  PubMed  CAS  Google Scholar 

  29. Poon RT, Fan ST, Tsang FH, Wong J. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon’s perspective. Ann Surg 2002; 235:466–486

    Article  PubMed  Google Scholar 

  30. Izzo F. Other thermal ablation techniques: microwave and interstitial laser ablation of liver tumors. Ann Surg Oncol 2003; 10:491–497

    Article  PubMed  Google Scholar 

  31. Shibata T, Iimuro Y, Yamamoto Y, et al. Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology 2002; 223:331–337

    Article  PubMed  Google Scholar 

  32. Lencioni RA, Allgaier HP, Cioni D, et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003; 228:235–240

    Article  PubMed  Google Scholar 

  33. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma ≤4 cm. Gastroenterology 2004; 127:1714–1723

    Article  PubMed  Google Scholar 

  34. Shiina S, Teratani T, Obi S, et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005; 129:122–130

    Article  PubMed  Google Scholar 

  35. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 2005; 54:1151–1156

    Article  PubMed  CAS  Google Scholar 

  36. Lencioni R, Cioni D, Crocetti L, et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 2005; 234:961–967

    Article  PubMed  Google Scholar 

  37. Tateishi R, Shiina S, Teratani T, et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 2005; 103:1201–1209

    Article  PubMed  Google Scholar 

  38. Koike Y, Shiratori Y, Sato S, et al. Risk factors for recurring hepatocellular carcinoma differ according to infected hepatitis virus––an analysis of 236 consecutive patients with a single lesion. Hepatology 2000; 32:1216–1223

    Article  PubMed  CAS  Google Scholar 

  39. Hanazaki K, Kajikawa S, Koide N, Adachi W, Amano J. Prognostic factors after hepatic resection for hepatocellular carcinoma with hepatitis C viral infection: univariate and multivariate analysis. Am J Gastroenterol 2001; 96:1243–1250

    Article  PubMed  CAS  Google Scholar 

  40. Zhou XD, Tang ZY, Yang BH, et al. Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma. Cancer 2001; 91:1479–1486

    Article  PubMed  CAS  Google Scholar 

  41. Wayne JD, Lauwers GY, Ikai I, et al. Preoperative predictors of survival after resection of small hepatocellular carcinomas. Ann Surg 2002; 235:722–730

    Article  PubMed  Google Scholar 

  42. Yanaga K. Current status of hepatic resection for hepatocellular carcinoma. J Gastroenterol 2004; 39:919–926

    Article  PubMed  Google Scholar 

  43. Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 2003; 226:441–451

    Article  PubMed  Google Scholar 

  44. Rhim H, Yoon KH, Lee JM, et al. Major complications after radio-frequency thermal ablation of hepatic tumors: spectrum of imaging findings. Radiographics 2003; 23:123–134

    Article  PubMed  Google Scholar 

  45. Choi D, Lim HK, Kim MJ, et al. Therapeutic efficacy and safety of percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the gastrointestinal tract. AJR: Am J Roentgenol 2004; 183:1417–1424

    Google Scholar 

  46. Choi D, Lim HK, Kim MJ, et al. Liver abscess after percutaneous radiofrequency ablation for hepatocellular carcinomas: frequency and risk factors. AJR: Am J Roentgenol 2005; 184:1860–1867

    Google Scholar 

  47. Lencioni R, Cioni D, Crocetti L, et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 2005; 234:961–967

    Article  PubMed  Google Scholar 

  48. Shibata T, Maetani Y, Isoda H, Hiraoka M. Radiofrequency ablation for small hepatocellular carcinoma: prospective comparison of internally cooled electrode and expandable electrode. Radiology 2006; 238:346–353

    Article  PubMed  Google Scholar 

Download references

AcknowledgEments

This study was supported by a grant from the Samsung Medical Center Clinical Research Development Program. We thank Kyong Hee Lee at Samsung Biomedical Research Institute for the data collection.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hyo K. Lim MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Choi, D., Lim, H.K., Rhim, H. et al. Percutaneous Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma After Hepatectomy: Long-term Results and Prognostic Factors. Ann Surg Oncol 14, 2319–2329 (2007). https://doi.org/10.1245/s10434-006-9220-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-006-9220-8

Keywords

Navigation